Research Article

Profiling of Peripheral TRBV and CD4+CD25+ Treg in CHB Patients with HBeAg SC during TDF Treatment

Table 1

Clinical and virological parameters in enrolled subjects at baseline.

VariablesSC ()Non-SC ()HCs ()

Age (years)
Gender (M/F)7/29/213/2
ALB (g/L)
ALT (U/L)
AST (U/L)
TBiL (μmol/L)
HBV genotype4B/5C5B/6CND
HBV DNA (lg, cps/mL)ND
HBsAg (lg, IU/mL)ND
HBeAg (lg, PEIU/mL)ND

These values are expressed as , unless otherwise indicated. Normal values:  U/L;  U/L; μmol/L; ALB 32~ 50 g/L. ALT: alanine transaminase; AST: aspartate aminotransferase; ALB: albumin; DNA: deoxyribonucleic acid; HBV: hepatitis B virus; HCs: healthy controls; TBiL: total bilirubin; ND: undetectable; non-SC: non HBeAg seroconverting; SC: HBeAg seroconverting. vs. non-SC.